equityflowunderstand the flow and follow it
EquityFlow › Companies › Cambrium

Cambrium

biotech · Berlin, DE

Protein-based specialty materials using biotechnology and generative AI.

In the network

Shares the most investors with (number = shared investors):
Motion 2

Funding history

DateRoundAmount
Nov 2024Funding round
Berlin-based Cambrium raised an undisclosed round led by Gradient Ventures to develop sustainable protein-based biomaterials.
—
Nov 2023Seed
Berlin synbio startup Cambrium raised a EUR8M seed led by Essential Capital to scale animal-free collagen production.
$8.6M

Investors

Tap an investor to see what else they have backed.

Essential CapitalGradient VenturesHOF CapitalValor Equity Partners

Other companies in biotech

Antag TherapeuticsAdcendoFreya BiosciencesTXN SystemsPromise BioConcinnity GeneticsNoema PharmaMabGenesisRadioNano TherapeuticsCitryllAlveron PharmaAQEMIA

Other companies in DE

NEURA RoboticsIsar AerospaceGALVANYPacifico BiolabsallOencosaBayshoreINXMNanoStructOmnisentProxima FusionPeec AI

Other companies at Unknown stage

&Charge/dev/agents123-Transporter123fahrschule13Hz1Global1Komma5°1MT Nation1Password20Face21.co2NA FISH
Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.